Transaction · 0001231589-26-000008

MAHON PAUL A

MAHON PAUL A, EVP, GC, reported an open-market or private sale at UNITED THERAPEUTICS Corp involving 1439.000000 shares for an estimated $760381.99. Reported holdings after the transaction were 51280.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SEVP, GC
UTHRUNITED THERAPEUTICS Corp
Filing timeMar 19
Trade dateMar 19, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$527.00
Pre-filing
1mo ago -8.5%1w ago +1.1%1d ago +0.6%
Returns since
7d +1.0%30d +11.6%90d +4.6%180d -1.7%1y -1.7%

UTHR price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
UTHR since 2026-03-19Filed 169 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001231589-26-000008
Common Stock
Transaction date
Mar 19, 2026
Filed Mar 19, 2026, 12:00 AM · 0d delay
Shares
1.43k sh
$52.8k per share
Estimated value
-$76.0M
Computed from shares × price
Holdings after
51.2k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Repeat Seller 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP & GENERAL COUNSEL

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.

  2. F2

    This transaction was executed in multiple trades at prices ranging from $526.99 to $527.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  3. F3

    This transaction was executed in multiple trades at prices ranging from $528.035 to $529.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to pro…

  4. F4

    This transaction was executed in multiple trades at prices ranging from $529.10 to $530.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  5. F5

    This transaction was executed in multiple trades at prices ranging from $530.11 to $531.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  6. F6

    This transaction was executed in multiple trades at prices ranging from $531.17 to $532.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  7. F7

    This transaction was executed in multiple trades at prices ranging from $532.19 to $532.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  8. F8

    This transaction was executed in multiple trades at prices ranging from $533.34 to $533.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

Original filing · 0001231589-26-000008
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

UTHR